Rock Creek Pharmaceuticals, Inc. announced earnings results for the third quarter ended September 30, 2014. The company recorded a net loss of approximately $10.0 million for the three months ended September 30, 2014, compared to a net loss of approximately $3.4 million for the same period in 2013. The increased net loss for the three months ended September 30, 2014 was primarily due to a discontinued operations charge, increases in stock based compensation, severance costs, directors' and officers' insurance, legal expenditures and research and development expenditures; and was partially offset by decreased loss from the dietary supplement business. For the three months ended September 30, 2014, the company had a basic and diluted loss per share of $0.05, compared to a basic and diluted loss per share of $0.02 for the comparable period in 2013.

For the three months ended September 30, 2014, the company also took a charge of $3.6 million consisting of inventory, specialized packaging machinery and other assets specifically related to the dietary supplement business.